Synthesis and characterization of arginine–glycine–aspartic peptides conjugated poly(lactic acid-co-l-lysine) diblock copolymer

A biodegradable Copolymer of poly(lactic acid-co-lysine)(PLA–PLL) was synthesized by a modified method and novel Arginine–Glycine–Aspartic (RGD) peptides were chemical conjugated to the primary ε-amine groups of lysine components in four steps: I to prepare the monomer of 3-(Nε-benzoxycarbonyl-l-lysine)-6-l-methyl-2,5-morpholinedione; II to prepare diblock copolymer poly(lactic acid-co-(Z)-l-lysine) (PLA–PLL(Z)) by ring-opening polymerization of monomer and l,l-lactide with stannous octoate as initiator; III to prepare diblock copolymer PLA–PLL by deprotected the copolymer PLA–PLL(Z) in HBr/HoAc solution; IV the reaction between RGD and the primary ε-amine groups of the PLA–PLL. The structure of PLA–PLL–RGD and its precursors were conformed by FTIR-Raman and 1H NMR. Low weight average molecular weight (9,200 g/mol) of the PLA–PLL was obtained and its PDI is 1.33 determined by GPC. The PLA–PLL contained 2.1 mol% lysine groups as determined by 1H NMR using the lysine protecting group’s phenyl protons. Therefore, the novel RGD-grafted diblock copolymer is expected to find application in drug carriers for tumor therapy or non-viral DNA carriers for gene therapy.

[1]  Robert Langer,et al.  Synthesis and RGD peptide modification of a new biodegradable copolymer: poly(lactic acid-co-lysine) , 1993 .

[2]  D. Elder,et al.  Integrin distribution in malignant melanoma: association of the beta 3 subunit with tumor progression. , 1990, Cancer research.

[3]  John Samuel,et al.  Poly(ethylene oxide)-block-poly(L-amino acid) micelles for drug delivery. , 2002, Advanced drug delivery reviews.

[4]  T. Park,et al.  Poly(L-lysine)-g-poly(D,L-lactic-co-glycolic acid) micelles for low cytotoxic biodegradable gene delivery carriers. , 2002, Journal of controlled release : official journal of the Controlled Release Society.

[5]  S. W. Kim,et al.  Lactose-poly(ethylene glycol)-grafted poly-L-lysine as hepatoma cell-tapgeted gene carrier. , 1998, Bioconjugate chemistry.

[6]  A. Maruyama,et al.  Nanoparticle DNA carrier with poly(L-lysine) grafted polysaccharide copolymer and poly(D,L-lactic acid). , 1997, Bioconjugate chemistry.

[7]  T. Mikkelsen,et al.  Angiogenesis in glioma: molecular mechanisms and roadblocks to translation. , 2003, Cancer journal.

[8]  S. Mousa Integrins as novel drug discovery targets: potential therapeutic and diagnostic implications , 2000 .

[9]  E Biganzoli,et al.  Vascular integrin alpha(v)beta3: a new prognostic indicator in breast cancer. , 1998, Clinical cancer research : an official journal of the American Association for Cancer Research.

[10]  Xu Xiangyang,et al.  Preparation and characterization of N-succinyl-N'-octyl chitosan micelles as doxorubicin carriers for effective anti-tumor activity. , 2007, Colloids and surfaces. B, Biointerfaces.

[11]  C. Barbas,et al.  Chemical adaptor immunotherapy: design, synthesis, and evaluation of novel integrin-targeting devices. , 2004, Journal of medicinal chemistry.

[12]  C. Kumar Integrin alpha v beta 3 as a therapeutic target for blocking tumor-induced angiogenesis. , 2003, Current drug targets.

[13]  A. Rademaker,et al.  Tumor angiogenesis correlates with metastatic disease, N-myc amplification, and poor outcome in human neuroblastoma. , 1996, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[14]  F. Liu,et al.  Polyethylene glycol-grafted poly-L-lysine as polymeric gene carrier. , 1998, Journal of controlled release : official journal of the Controlled Release Society.

[15]  H. Uludaǧ,et al.  Conjugation of arginine-glycine-aspartic acid peptides to poly(ethylene oxide)-b-poly(epsilon-caprolactone) micelles for enhanced intracellular drug delivery to metastatic tumor cells. , 2007, Biomacromolecules.

[16]  D. Cheresh,et al.  Requirement of vascular integrin alpha v beta 3 for angiogenesis. , 1994, Science.

[17]  R. Hwang,et al.  The role of integrins in tumor angiogenesis. , 2004, Hematology/oncology clinics of North America.

[18]  K. Zatloukal,et al.  Influenza virus hemagglutinin HA-2 N-terminal fusogenic peptides augment gene transfer by transferrin-polylysine-DNA complexes: toward a synthetic virus-like gene-transfer vehicle. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[19]  Robert Langer,et al.  Copolymerization and Degradation of Poly(lactic acid-co-lysine) , 1995 .

[20]  S. Sahoo,et al.  Characterization of porous PLGA/PLA microparticles as a scaffold for three dimensional growth of breast cancer cells. , 2005, Biomacromolecules.

[21]  W. Pitt,et al.  Further investigation of the mechanism of Doxorubicin release from P105 micelles using kinetic models. , 2007, Colloids and surfaces. B, Biointerfaces.

[22]  P. Black,et al.  αvβ3 and αvβ5 Integrin Expression in Glioma Periphery , 2001 .

[23]  S. W. Kim,et al.  pH-sensitive cationic polymer gene delivery vehicle: N-Ac-poly(L-histidine)-graft-poly(L-lysine) comb shaped polymer. , 2000, Bioconjugate chemistry.

[24]  Erkki Ruoslahti,et al.  Cell attachment activity of fibronectin can be duplicated by small synthetic fragments of the molecule , 1984, Nature.

[25]  Dirk W. Grijpma,et al.  Lewis acid catalyzed polymerization of L-lactide. Kinetics and mechanism of the bulk polymerization , 1992 .

[26]  Teruo Okano,et al.  Enhanced tumor accumulation and prolonged circulation times of micelle-forming poly(ethylene oxide-aspartate) block copolymer-Adriamycin conjugates , 1994 .

[27]  Yuichi Ohya,et al.  Formation of core-shell type biodegradable polymeric micelles from amphiphilic poly(aspartic acid)-block-polylactide diblock copolymer. , 2005, Biomacromolecules.